Screening compound: InChI=1S/C19H14ClN3OS/c20-15-8-6-13(7-9-15)10-17-22-18(24-23-17)11-19-21-16(12-25-19)14-4-2-1-3-5-14/h1-9,12H,10-11H2

Screening compound: InChI=1S/C19H14ClN3OS/c20-15-8-6-13(7-9-15)10-17-22-18(24-23-17)11-19-21-16(12-25-19)14-4-2-1-3-5-14/h1-9,12H,10-11H2
Screening compound: InChI=1S/C19H14ClN3OS/c20-15-8-6-13(7-9-15)10-17-22-18(24-23-17)11-19-21-16(12-25-19)14-4-2-1-3-5-14/h1-9,12H,10-11H2 alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C19H14ClN3OS/c20-15-8-6-13(7-9-15)10-17-22-18(24-23-17)11-19-21-16(12-25-19)14-4-2-1-3-5-14/h1-9,12H,10-11H2

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

M040-0937

Molecular Formula

C19H14ClN3OS (C19 H14 ClN3 OS)

Compound Name

3-[(4-chlorophenyl)methyl]-5-[(4-phenyl-1,3-thiazol-2-yl)methyl]-1,2,4-oxadiazole

IUPAC name

3-[(4-chlorophenyl)methyl]-5-[(4-phenyl-13-thiazol-2-yl)methyl]-124-oxadiazole

SMILES

Clc1ccc(Cc2noc(Cc3nc(-c4ccccc4)cs3)n2)cc1

InChI

InChI=1S/C19H14ClN3OS/c20-15-8-6-13(7-9-15)10-17-22-18(24-23-17)11-19-21-16(12-25-19)14-4-2-1-3-5-14/h1-9,12H,10-11H2

InChI Key

KBFXJXCDPIUWJV-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD20736429

InChI=1S/C19H14ClN3OS/c20-15-8-6-13(7-9-15)10-17-22-18(24-23-17)11-19-21-16(12-25-19)14-4-2-1-3-5-14/h1-9,12H,10-11H2 in Drug Discovery

Included in Screening Libraries

Anti-Aging Library (44940 compounds)

GPCR Targeted Library (31838 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

SmartTM Library (51161 compounds)

Targeted Diversity Library (40567 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Mechanism of action:
  • Epigenetic
  • Receptor's ligands
Targets:
  • GPCR
  • Kinases

References: we are preparing a list of scientific research reports with InChI=1S/C19H14ClN3OS/c20-15-8-6-13(7-9-15)10-17-22-18(24-23-17)11-19-21-16(12-25-19)14-4-2-1-3-5-14/h1-9,12H,10-11H2 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C19H14ClN3OS/c20-15-8-6-13(7-9-15)10-17-22-18(24-23-17)11-19-21-16(12-25-19)14-4-2-1-3-5-14/h1-9,12H,10-11H2?
Check Price and Availability of InChI=1S/C19H14ClN3OS/c20-15-8-6-13(7-9-15)10-17-22-18(24-23-17)11-19-21-16(12-25-19)14-4-2-1-3-5-14/h1-9,12H,10-11H2, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C19H14ClN3OS/c20-15-8-6-13(7-9-15)10-17-22-18(24-23-17)11-19-21-16(12-25-19)14-4-2-1-3-5-14/h1-9,12H,10-11H2 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C19H14ClN3OS/c20-15-8-6-13(7-9-15)10-17-22-18(24-23-17)11-19-21-16(12-25-19)14-4-2-1-3-5-14/h1-9,12H,10-11H2
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C19H14ClN3OS/c20-15-8-6-13(7-9-15)10-17-22-18(24-23-17)11-19-21-16(12-25-19)14-4-2-1-3-5-14/h1-9,12H,10-11H2
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C19H14ClN3OS/c20-15-8-6-13(7-9-15)10-17-22-18(24-23-17)11-19-21-16(12-25-19)14-4-2-1-3-5-14/h1-9,12H,10-11H2 available by request